Utilizing MRD Testing in the Myeloma SpaceByGayathri Ravi, MDApril 10th 2023Gayathri Ravi, MD, discusses the role minimal residual disease plays in decision making and treating patients with hematologic malignancies.
Evaluating MRD Testing in the Real-World Setting for Patients Multiple MyelomaByGayathri Ravi, MDJanuary 20th 2023Gayathri Ravi, MD, discusses the role of minimal residual disease testing in patients with newly diagnosed multiple myeloma.